Mapping effector genes at lupus GWAS loci using promoter Capture-C in follicular helper T cells.
Chun SuMatthew E JohnsonAnnabel TorresRajan M ThomasElisabetta ManduchiPrabhat SharmaParul MehraCarole Le CozMichelle E LeonardSumei LuKenyaita M HodgeAlessandra ChesiJames A PippinNeil RombergStruan F A GrantAndrew D WellsPublished in: Nature communications (2020)
Systemic lupus erythematosus (SLE) is mediated by autoreactive antibodies that damage multiple tissues. Genome-wide association studies (GWAS) link >60 loci with SLE risk, but the causal variants and effector genes are largely unknown. We generated high-resolution spatial maps of SLE variant accessibility and gene connectivity in human follicular helper T cells (TFH), a cell type required for anti-nuclear antibodies characteristic of SLE. Of the ~400 potential regulatory variants identified, 90% exhibit spatial proximity to genes distant in the 1D genome sequence, including variants that loop to regulate the canonical TFH genes BCL6 and CXCR5 as confirmed by genome editing. SLE 'variant-to-gene' maps also implicate genes with no known role in TFH/SLE disease biology, including the kinases HIPK1 and MINK1. Targeting these kinases in TFH inhibits production of IL-21, a cytokine crucial for class-switched B cell antibodies. These studies offer mechanistic insight into the SLE-associated regulatory architecture of the human genome.
Keyphrases
- systemic lupus erythematosus
- genome wide
- copy number
- disease activity
- genome wide identification
- dna methylation
- transcription factor
- high resolution
- genome wide association
- regulatory t cells
- genome editing
- crispr cas
- endothelial cells
- dendritic cells
- genome wide analysis
- bioinformatics analysis
- rheumatoid arthritis
- lymph node
- induced pluripotent stem cells
- mass spectrometry
- genome wide association study
- risk assessment
- immune response
- case control